:::

詳目顯示

回上一頁
題名:照護一位服用抗精神病藥物致體重過重患者之護理經驗
書刊名:護理雜誌
作者:蘇妙秋許禎娟林彥如曾雯琦
作者(外文):Su, Miao-chiuHsu, Chen-chuanLin, Yen-ruTzeng, Wen-chii
出版日期:2007
卷期:54:1
頁次:頁90-96
主題關鍵詞:精神分裂症體重過重第二代抗精神病藥物SchizophreniaOverweight2nd generation antipsychotics
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(1) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:1
  • 共同引用共同引用:0
  • 點閱點閱:832
本文描述照護一位因服用抗精神病藥物致體重過重之精神分裂症患者的護理經驗,護理期間為93年5月1日至93年6月10日,筆者以整體性護理評估為指引,並藉由觀察及會談方式來收集資料,發現個案有:(1) 感覺及知覺紊亂、(2) 營養不均衡:多於身體需要、(3) 無效性健康維護能力三個護理問題。護理人員經治療性人際關係的建立,教導有效處理幻聽干擾之技巧與提供個別性的減重計畫,不但使個案於住院期間受幻聽干擾頻率減少、減輕體重5.5公斤,並且讓個案能修正對疾病與藥物的錯誤信念。因此,筆者建議精神科護理人員可以運用個別性減重計畫來協助病人改善因為使用第二代抗精神病藥物所產生之體重過重情形,讓病人能以正向的態度來面對疾病,改善服藥順從性,提升自我健康維護能力。
The purpose of this article is to describe a nursing experience with a patient with schizophrenia who had antipsychotics-induced overweight. The authors assessed the patient's health condition and provided weight management to reduce her hallucinations as well as her body weight between May 1 and June 10, 2004. Three nursing problems had been identified as follows: disturbed sensory perception, imbalanced nutrition, and ineffective health maintenance. During the nursing process, the authors established a rapport relationship with the patient and her mother, educated them in skills for reducing hallucinations, and designed an individual body weight management program. After the interventions, the patient was able to positively face her illness, effectively use methods to reduce the impact of hallucinations, and successfully lose 5.5kg. From this perspective, an individual body weight management program can be an effective intervention for nurses to care for this group of patients.
期刊論文
1.Allison, D. B.、Mentore, J. L.、Heo, M.、Chandler, L. R.、Cappelleri, J. C.、Infante, M. C.(1999)。Antipsychotic-induced weight gain: A comprehensive research synthesis。American Journal of Psychiatry,156(11),1686-1696。  new window
2.Basson, B. R.、Kinon, B. J.、Taylor, C. C.、Szymanski, K. A.、Gilmore, J. A.、Tollefson, G. D.(2001)。Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone。Journal of Clinical Psychiatry,62(4),231-238。  new window
3.Gerlach, J.(2002)。Improving outcome in schizophrenia: The potential importance of EPS and neuroleptic dysphoria。Annals of Clinical Psychiatry,14(1),47-57。  new window
4.Harrison, B.(2004)。Nursing considerations in psychotropic medication-induced weight gain。Clinical Nurse Specialist,18(2),80-87。  new window
5.Lieberman, J. A.、Tollefson, G.、Tohen, M.、Green, A. I.、Gur, R. E.、Kahn, R.(2003)。Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: A randomized, double-blind trial of olanzapine versus haloperidol。American Journal of Psychiatry,160(8),1396-1404。  new window
6.Umbricht, D.、Flury, H.、Bridler, R.(2001)。Cognitive behavior therapy for weight gain。American Journal of Psychiatry,158(6),971。  new window
7.林立寧、何曉旭、林信男(20040900)。第二代抗精神病藥物對體重的影響。臺灣醫學,8(5),722-726。  延伸查詢new window
8.曾雯琦、楊政議、林彥如、陸汝斌(20050700)。第二代抗精神病藥物誘發體重增加之非藥物處理。臺灣醫學,9(4),536-539。  延伸查詢new window
9.Kurzthaler, I. K.、Fleischhaker, W. W.(2001)。The clinical implications of weight gain in schizophrenia。Journal of Clinical Psychiatric,62(Suppl. 7),32-37。  new window
10.Taylor, D. M.、McAskill, R.(2000)。Atypical Antipsychotics and Weight Gain--A Systematic Review。Acta Psychiatrica Scandinavica,101(6),416-432。  new window
11.Werneke, U.、Taylor, D.、Sanders, T. A.、Wessely, S.(2003)。Behavioural management of antipsychotic-induced weight gain: a review。Acta Psychiatry Scand,108(4),252-259。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
QR Code
QRCODE